20896 ⎘
Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Tripeptides
Peptide conjugated anti-cancer prodrugs
#1202Advanced glycation end-product intermediaries and post-amadori inhibition
#1203Peptide having an ace inhibiting effect
#1204Methods for reducing CD36 expression
#1205Compounds for enzyme inhibition
#1206Process for the manufacture of peptide facilitators of reverse cholesterol transport
#1207Therapeutic agent for iNOS generating illness
#1208Prodrugs of T3 and T4 with enhanced bioavailability
#1209Hydrogel compositions
#1210Selective inhibition of proteasomes of tuberculosis and other bacteria
#1211Growth hormone secretagogue receptor type 1A agonists
#1212Use of colostrinin, constituent peptides thereof, and analogs thereof as modulators of intracellular signaling molecules
#1213Proteaseome inhibitors for the treatment of herpesviridae infected individuals
#1214Inhibition of cell motility, angiogenesis, and metastasis
#1215Compositions and methods for modulating connexin hemichannels
#1216TREATMENT OF PROLIFERATIVE DISORDERS
#1217Molecules that block viral infectivity and methods of use thereof
#1218Composition for the prevention and treatment of cellulitis
#1219Liver/plasma concentration ratio for dosing hepatitis C virus protease inhibitor
#1220Treatment of tumors using short peptides from human chorionic gonadotropin (HCG)
#1221Methods of using macrocyclic modulators of the ghrelin receptor
#1222Prodrug compounds with isoleucine
#1223Use of Inhibitors of the Ubiquitin Proteasome Pathway as a Method of Increasing Contractility of the Heart
#1224INTEGRIN BINDING MOTIF CONTAINING PEPTIDES AND METHODS OF TREATING SKELETAL DISEASES
#1225Therapeutic agents for low HDL-cholesterolemia
#1226Pharmaceutical formulations and methods of treatment using the same
#1227Inhibitors of signal transduction and activator of transcription 3
#1228Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
#1229Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
#1230Remedy for eye diseases accompanied by optic nerve injuries
#1231Method for modulating activity of HCV protease through use of a novel HCV protease inhibitor to reduce duration of treatment period
#1232Administration of HCV protease inhibitors in combination with food to improve bioavailability
#1233Methods of treating hepatitis C virus
#1234Tripeptide of FcyRIIA
#1235Method for lowering serum homocysteine
#1236Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis
#1237Use of at least one $g(a)62 casein peptide with angiotensin i converting enzyme inhibiting activity for preparing medicines, food products and food complements
#1238Cardioprotective agent
#1239Methods for improving the structure and function of arterioles
#1240Identification of n-alkylglycine trimers for induction of apoptosis
#1241Methods and compounds for inhibiting beta-amyloid peptide release and/or its synthesis
#1242Biologically active substance of a vasoactive intestinal peptide for treating interstitial lung diseases
#1243Neuronal pain pathway
#1244Treatment of multiple sclerosis with brain targeted anti oxidant compounds
#1245Methods and compositions for the treatment of parkinson's disease and other alpha-synucleinopathies
#1246Treatment of neuropsychiatric disease with protease and neuraminidase inhibitors
#1247Use of a proteasome inhibitor in the treatment of endothelial dysfunction and/or in a low-dose proteasome inhibitor therapy
#1248Use of effectors of glutaminyl and glutamate cyclases
#1249Anti-hypertensive dietary supplement
#1250Use of a polypeptide for treatment of pruritus in animals
#1251Aza-peptide epoxides
#1252Hepatitis C virus inhibitors
#1253Compositions for preventing and treating digestive organs diseases
#1254Oxidised lipids as reversal agents for boronic acid drugs
#1255Hair tonics and method of screening the same
#1256Compositions capable of reducing elevated blood urea concentration
#1257Compositions and methods comprising protein activated receptor antagonists
#1258Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (iap)
#1259AT4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents
#1260Therapeutic agents for low HDL-cholesterolemia
#1261Drug for preventing, regulating or treating adhesion
#1262Method for obtaining anti-idiotype antibodies
#1263Combination product comprising melagatran and an anti-arrhythmic oxabispidenes
#1264Reducing axon degeneration with proteasome inhibitors
#1265Treatment of pain by inhibition of caspase signaling
#1266Use of poly-amminopyrrolecarboxamides alone or in combination with a cyclodextrin in the prophylaxis and treatment of animal parasitosis
#1267Paclitaxel hybrid derivatives
#1268Peptide inhibitors of smac protein binding to inhibitor of apoptosis proteins (IAP)
#1269Polyethylene glycol - peptide copper complexes and compositions and methods related thereto
#1270Method for inhibition of viral infection
#1271Identification and use of growth hormone secretagogue receptor type 1A antagonists
#1272Drug therapy for Celiac Sprue
#1273Cutanceous metabolic bio-activator
#1274Composition for promoting lacrimal secretion
#1275Na+ and CI-coupled transport system for endogenous opioid peptides
#1276Nebulized pharmaceutical compositions for the treatment of bronchial disorders
#1277Cosmetic or pharmaceutical composition comprising peptides, uses and treatment processes
#1278Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm
#1279Use of a compound for enhancing the expression of membrane proteins on the cell surface
#1280Methods of inhibiting glutamate receptors by administering the tripeptide KDI
#1281Oral delivery of peptide pharmaceutical compositions
#1282Function of autophagy genes in cell death
#1283Nutritional and therapeutic composition of an insulin sensitizer and a peptide fraction
#1284Sensitization to another anticancer therapy and/or amelioration of a side effect of another anitcancer therapy by treatment with a GST-activated anticancer compound
#1285Pharmaceutical composition comprising a retro-iverso isomer peptide
#1286Propenoyl hydrazides
#1287Hemiasterlin derivatives and uses thereof
#1288Caspase inhibitors and uses thereof
#1289Treating infectious diseases using ice inhibitors
#1290Drug complex for treatment of metastatic prostate cancer
#1291Compositions capable of reducing elevated blood urea concentration
#1292Pharmaceutical preparations of glutathione and methods of administration thereof
#1293AT4 receptor ligands as angiogenic, anti-angiogenic, and anti-tumor agents
#1294Use of proteasome inhibitor in the treatment of fibrotic diseases
#1295Vitamin directed targeting therapy
#1296Di-, tri-, and tetra-peptides having antiangiogenic activity
#1297Metal-binding compounds and uses therefor
#1298Methods of controlling proliferation and differentiation of stem and progenitor cells
#1299Cyclobutenedione-containing compounds as inhibitors of hepatitis C virus NS3 serine protease
#1300Compositions and methods for treatment of rosacea
#1301Agents for treating flaviviridaeinfections
#1302Compositions and methods for treatment of Psoriasis
#1303Tripeptide derivatives for the treatment of neurodegenerative diseases
#1304Compounds and compositions for prevention of overdose of oxycodone
#1305Dipeptidyl peptidase IV inhibitors and their uses as anti-cancer agents
#1306Proteaseome inhibitors for the treatment of herpesviridae infected individuals
#1307Methods and formulations for treating glaucoma
#1308Integrin binding motif containing peptides and methods of treating skeletal diseases
#1309Composition for the treatment of infection by Flaviviridae viruses
#1310Methods and compositions for measuring natriuretic peptides and uses thereof
#1311Inhibitors of proteasomal activity for stimulating hair growth
#1312Methods for preserving the viability of photoreceptor cells by anti-FAS-ligand/anti-FAS-receptor antibodies
#1313Methods of controlling proliferation and differentiation of stem and progenitor cells
#1314Tripeptide derivatives for the treatment of postlesional diseases of the nervous system
#1315Drug delivery to the inner ear and methods of using same
#1316Drugs ameliorating hypo-hdl cholesterolemia
#1317Tripeptides and tripeptide derivatives for the treatment of postlesional disease of the nervous system
#1318Stabilization of pharmaceutical protein formulations with small peptides
#1319Inhibitor of cardiac tachyarrhythmias
#1320Glutamine for use in treating injury
#1321Elastin peptide analogs and uses thereof
#1322Inhibitors of plasmepsins
#1323Composition and method of treatment for urogenital conditions
#1324Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof
#1325Pharmaceutical/cosmetic compositions comprising the lysine-D-proline-valine tripeptide
#1326Inhibitors of proteasomal activity for stimulating hair growth
#1327Hepatitis C inhibitor compounds
#1328Use of calpain for identifying compounds that modulate pain
#1329Use of proton sequestering agents in drug formulations
#1330Tri-peptides for neurological and neurobehavioral applications
#1331Egg white protein anti-inflammatory peptide and application thereof
#1332Compositions and methods for hair treatment
#1333Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof
#1334Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof
#1335Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof
#1336Pristinamycin compositions, LPXC compositions, their improvements, and combinations thereof
#1337Covalent granzyme B inhibitors
#1338Proline compounds as Granzyme B inhibitors
#1339Pristinamycin compositions, LpxC compositions, their improvements, and combinations thereof
#13404-Fluoro-Thio-containing inhibitors of APP2, compositions thereof and method of use